US hospitals report rising refusals of newborn preventive care

Refusals of routine newborn preventive care in the US are rising beyond vaccines, with vitamin K shots a prominent example. The Independent reports that an Idaho pediatrician recently saw days when roughly half of newborns did not receive the injection, and other days when more than a quarter declined it—levels that used to be unusual in hospital settings.

The broader trend is visible in national data. A study in the Journal of the American Medical Association, cited by The Independent, analysed more than five million births and found vitamin K refusals nearly doubled between 2017 and 2024, from 2.9% to 5.2%. Clinicians interviewed in the report say the same families often refuse the hepatitis B vaccine given at birth and erythromycin eye ointment used to prevent severe eye infections, including those caused by gonorrhoea acquired during delivery.

The medical consequences are not theoretical. Babies are born with low vitamin K levels and cannot produce enough via gut bacteria until months later, leaving them vulnerable to vitamin K deficiency bleeding, including intracranial bleeding. The Independent cites research indicating that newborns who skip the shot are 81 times more likely to develop severe bleeding than those who receive it. In Idaho, paediatricians told a February meeting of the state chapter of the American Academy of Pediatrics that they knew of eight deaths from vitamin K deficiency bleeding over the previous 13 months.

What changes for hospitals is not only the risk profile but the operating model. “Standard of care” becomes a negotiation, and risk management shifts from a default protocol to case-by-case documentation and contingency planning. Preventive measures such as vitamin K, eye ointment, and early vaccination are designed for population-scale reliability: they are cheap, quick, and administered before complications appear. When parents opt out, the system still inherits the tail risk—emergency transfers, intensive care, lifelong disability—because the same hospitals are expected to treat the outcome.

The report links the shift to a mix of medical mistrust and online information ecosystems that frame long-established interventions as optional or suspicious. It also notes a political tailwind: a federal advisory committee reconstituted by Health Secretary Robert F. Kennedy Jr., described by The Independent as a leading anti-vaccine activist before joining the administration, voted to end the longstanding recommendation to immunise all babies against hepatitis B immediately after birth. A federal judge has temporarily blocked the committee’s decisions.

Hospitals can counsel, document refusals, and try to persuade, but they cannot price the risk back to the decision-maker in real time. A vitamin injection that costs little is being declined; the downstream cost of a brain bleed is measured in ICU beds, rehabilitation, and special education.

In one Idaho ward, Dr Tom Patterson said the change is visible on a single shift: babies leave without a shot introduced in 1961, and the paperwork gets heavier as the prevention gets lighter.